Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olorofim in Early Coccidioidal Meningitis
NCT07385638Phase 2Recruiting
- Sponsor
- Fariba Donovan
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olorofim in Coccidioidal meningitis (CM), sponsored by Fariba Donovan. Started Jun 2026; status: recruiting.
02
Drugs
olorofim
03
Conditions
Coccidioidal meningitis (CM)
Beyond the preview
Go deeper on NCT07385638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07385638.